Topical or oral corticosteroids generally cost $10 to $20 a month.
Discover why psoriasis treatments may lose effectiveness and explore alternatives. Learn about the potential of biologics, systemic therapies, and more to manage symptoms.
Ustekinumab showed longer drug survival than adalimumab and secukinumab in biologic-naive psoriasis patients in Denmark. Bimekizumab, guselkumab, and risankizumab had lower discontinuation risks in ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Should you see ...
The patient described earlier highlights important clinical points regarding the complex management of psoriasis. First, we must recognize that her obesity, hypertension, dyslipidemia, and non-insulin ...
Risankizumab improved visible psoriasis and reduced subclinical vascular inflammation on optical coherence tomography over 52 ...
Psoriasis is an autoimmune disease that affects over 7.5 million adults in the United States. It’s a chronic condition that currently has no cure. Plaque psoriasis is the most common type, accounting ...
Patients with psoriasis are at increased risk for cataracts, uveitis, dry eye disease, glaucoma, retinal vein occlusion (RVO) ...
Hormonal fluctuations during pregnancy can increase the risk of psoriasis in nearly 10–20 per cent of women, health experts ...
Hormonal fluctuations during pregnancy can increase the risk of psoriasis in nearly 10–20 per cent of women, health experts ...